Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity. Issue 8 (10th June 2019)
- Record Type:
- Journal Article
- Title:
- Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity. Issue 8 (10th June 2019)
- Main Title:
- Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity
- Authors:
- Figueiredo, Constança
Oldhafer, Felix
Wittauer, Eva‐Maria
Carvalho‐Oliveira, Marco
Akhdar, Ali
Beetz, Oliver
Chen‐Wacker, Chen
Yuzefovych, Yuliia
Falk, Christine S.
Blasczyk, Rainer
Vondran, Florian W.R. - Abstract:
- Abstract: In contrast to the whole liver, primary hepatocytes are highly immunogenic. Thus, alternative strategies of immunomodulation after hepatocyte transplantation are of special interest. Silencing of HLA class I expression is expected to reduce the strength of allogeneic immune responses and to improve graft survival. In this study, primary human hepatocytes (PHH) were isolated using a two‐step‐collagenase perfusion‐technique and co‐cultured with allogeneic lymphocytes in terms of a mixed lymphocyte hepatocyte culture. Expression of HLA class I on PHH was silenced using lentiviral vectors encoding for β2‐microglobulin‐specific short hairpin RNA (shβ2m) or non‐specific shRNA (shNS) as control. The delivery of shβ2m into PHH caused a decrease by up to 96% in β2m transcript levels and a down‐regulation of HLA class I cell surface expression on PHH by up to 57%. Proliferative T cell alloresponses against HLA‐silenced PHH were significantly lower than those observed form fully HLA‐expressing PHH. In addition, significantly lower secretion of pro‐inflammatory cytokines was observed. Levels of albumin, urea and aspartate‐aminotransferase did not differ in supernatants of cultured PHH. In conclusion, silencing HLA class I expression on PHH might represent a promising approach for immunomodulation in the transplant setting without compromising metabolic function of silenced hepatocytes.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 23:Issue 8(2019)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 23:Issue 8(2019)
- Issue Display:
- Volume 23, Issue 8 (2019)
- Year:
- 2019
- Volume:
- 23
- Issue:
- 8
- Issue Sort Value:
- 2019-0023-0008-0000
- Page Start:
- 5705
- Page End:
- 5714
- Publication Date:
- 2019-06-10
- Subjects:
- cell transplantation -- hepatocyte -- hepatocyte transplantation -- HLA silencing -- immune response -- Immunomodulation -- immunosuppression
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.14484 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23367.xml